Literature DB >> 18341608

Inclusion body myopathy, Paget's disease of the bone and frontotemporal dementia: recurrence of the VCP R155H mutation in an Italian family and implications for genetic counselling.

V Viassolo1, S C Previtali, E Schiatti, G Magnani, C Minetti, F Zara, M Grasso, F Dagna-Bricarelli, E Di Maria.   

Abstract

The acronym IBMPFD denotes a syndrome including inclusion body myopathy, Paget's disease of the bone (PDB) and frontotemporal dementia (FTD) as cardinal features, which is caused by missense mutations in the VCP gene. We studied the clinical characteristics and the histopathological features in two siblings and their mother who presented with adult-onset myopathy and presenile, rapidly progressive FTD. One sibling also showed PDB. Light and electron microscopy performed on muscle biopsies demonstrated degenerative changes with inclusion bodies and abnormal aggregates. Mutation analysis of the VCP gene on affected siblings revealed a heterozygous missense mutation (R155H) in a hot spot. This is the first Italian family with multiple individuals diagnosed as having IBMPFD and carrying the recurrent R155H mutation. The implications for genetic counselling were also discussed, with regard to the procedures that may be offered to families suffering from a multisystem disorder with high risk of cognitive decline.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18341608     DOI: 10.1111/j.1399-0004.2008.00984.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  15 in total

Review 1.  Fission and fusion of the neuronal endoplasmic reticulum.

Authors:  K Kucharz; T Wieloch; H Toresson
Journal:  Transl Stroke Res       Date:  2013-08-24       Impact factor: 6.829

2.  Paget's Disease of Bone: A Review of Epidemiology, Pathophysiology and Management.

Authors:  Joseph L Shaker
Journal:  Ther Adv Musculoskelet Dis       Date:  2009-04       Impact factor: 5.346

Review 3.  Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Suvi Häkkinen; Stephanie A Chu; Suzee E Lee
Journal:  Neurobiol Dis       Date:  2020-09-02       Impact factor: 5.996

Review 4.  A Brazilian family with inclusion body myopathy associated with Paget's disease of bone and frontotemporal dementia linked to the VCP pGly97Glu mutation.

Authors:  Samuel Katsuyuki Shinjo; Sueli Mieko Oba-Shinjo; Antonio Marcondes Lerario; Suely Kazue Nagahashi Marie
Journal:  Clin Rheumatol       Date:  2017-11-10       Impact factor: 2.980

5.  Targeted excision of VCP R155H mutation by Cre-LoxP technology as a promising therapeutic strategy for valosin-containing protein disease.

Authors:  Angèle Nalbandian; Katrina J Llewellyn; Christopher Nguyen; Edward S Monuki; Virginia E Kimonis
Journal:  Hum Gene Ther Methods       Date:  2015-02       Impact factor: 2.396

6.  Novel mutation in VCP gene causes atypical amyotrophic lateral sclerosis.

Authors:  Paloma González-Pérez; Elizabeth T Cirulli; Vivian E Drory; Ron Dabby; Puiu Nisipeanu; Ralph L Carasso; Menachem Sadeh; Andrew Fox; Barry W Festoff; Peter C Sapp; Diane McKenna-Yasek; David B Goldstein; Robert H Brown; Sergiu C Blumen
Journal:  Neurology       Date:  2012-11-14       Impact factor: 9.910

7.  The homozygote VCP(R¹⁵⁵H/R¹⁵⁵H) mouse model exhibits accelerated human VCP-associated disease pathology.

Authors:  Angèle Nalbandian; Katrina J Llewellyn; Masashi Kitazawa; Hong Z Yin; Mallikarjun Badadani; Negar Khanlou; Robert Edwards; Christopher Nguyen; Jogeshwar Mukherjee; Tahseen Mozaffar; Giles Watts; John Weiss; Virginia E Kimonis
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

8.  Psychological Impact of Predictive Genetic Testing for Inherited Alzheimer Disease and Frontotemporal Dementia: The IT-DIAfN Protocol.

Authors:  Samantha Galluzzi; Anna Mega; Giuseppe Di Fede; Cristina Muscio; Sara Fascendini; Luisa Benussi; Fabrizio Tagliavini; Giovanni B Frisoni; Emilio Di Maria
Journal:  Alzheimer Dis Assoc Disord       Date:  2022-03-16       Impact factor: 2.357

9.  Rapamycin and chloroquine: the in vitro and in vivo effects of autophagy-modifying drugs show promising results in valosin containing protein multisystem proteinopathy.

Authors:  Angèle Nalbandian; Katrina J Llewellyn; Christopher Nguyen; Puya G Yazdi; Virginia E Kimonis
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

10.  Exercise training reverses skeletal muscle atrophy in an experimental model of VCP disease.

Authors:  Angèle Nalbandian; Christopher Nguyen; Veeral Katheria; Katrina J Llewellyn; Mallikarjun Badadani; Vincent Caiozzo; Virginia E Kimonis
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.